Ignite Creation Date:
2024-05-06 @ 7:21 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02513667
Status:
TERMINATED
Last Update Posted:
2023-02-03
First Post:
2015-07-30
Brief Title:
Ceritinib in Combination With Stereotactic Ablative Radiation Metastatic Lung Adenocarcinoma
Sponsor:
University of Texas Southwestern Medical Center
Organization:
University of Texas Southwestern Medical Center
Organization Data
Organization:
University of Texas Southwestern Medical Center
Class:
OTHER
Study ID:
STU 042015-076
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of Texas Southwestern Medical Center
Lead Sponsor Class:
OTHER
Responsible Party:
Sawsan Rashdan
Responsible Party Title:
Assistant Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
University of Texas Southwestern Medical Center
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Novartis Pharmaceuticals | INDUSTRY |